Browse Penn-owned technologies available for licensing.
Bottom Figure: This technology has the potential to treat damaged tissues. The first option restores fluid flow with a barrier at the focal defect interface and reduces the rate of degeneration. The second option would promote cartilage repair. The third would direct cells to the defect, providing an anti-inflammatory benefit, and improving the healing process. Currently, the proposed technique is option one, or a living fibrous “biosealant’.